As the use of popular weight loss and diabetes drugs like Wegovy and Ozempic skyrockets, consumer brands are scrambling to adapt. But health professionals are warning consumers not to take medical advice from the same companies trying to sell them food, supplements and other consumables.
The new GLP-1 drugs, as they’re known, are prompting hopes – and fears – of a seismic shift in the food industry, potentially impacting what and how much people eat. JP Morgan said last year that users of the diabetes and weight loss drugs drugs — which help control blood
→ Continue reading at CNN - Business News